The provision of Low Risk Basal Cell Carcinoma (BCC) - Skin Cancer and Dermatology Service

The provision of Low Risk Basal Cell Carcinoma (BCC) service providing Consultant Led Dermatology to NHS Greater Manchester Integrated Care Board (NHS GM ICB)

This contract will be for 6-months from 1st April 2025 - 30th September 2025.

The total value of this contract will be £3,525.000.

This is a Provider Selection Regime (PSR) Direct Award Process C intention to award notice, this notice serves as an intention to award under the PSR.

The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of The Procurement Act 2023 Regulations do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to decision makers by midnight on 22nd August 2025.

This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.

Written representations should be sent to: [email protected]

Key Award Criteria - Quality and innovation - 20%, Value 20%, Integration, collaboration and service sustainability - 20%, improving access, reducing health inequalities and facilitating choice - 20% and Social Value - 20%.

Award decision-makers: Corporate Director of Finance - Commissioning & Financial Assurance and the Executive Committee on behalf on NHS Greater Manchester Integrated Care Board.

No conflicts of interest were declared.